Prosomnus Investor Relations Material

ProSomnus Inc is a medical technology company specializing in the development, manufacturing, and marketing of precision intraoral medical devices. These devices are designed to treat and manage obstructive sleep apnea (OSA), a condition that affects a significant portion of the global population. The company's innovative approach involves creating customized oral appliance therapy devices, offering a non-CPAP alternative for OSA treatment. ProSomnus sells its products through a direct sales force to a variety of healthcare providers, including sleep dentists, sleep physicians, primary care providers, and otolaryngologists, aiming to provide an effective solution for the management of sleep apnea. The company is headquartered in Pleasanton, California, and its shares are listed on the Nasdaq.